2811 - 2820 of 6466 Results
Title
Year
-
OPENTitle: Long read sequencing reveals transgene concatemerization and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotesJournal Name: Frontiers in Genome EditingPublisher: Frontiers Media SAVol: 7Issue #:Start Page: 1582097End Page: 1582097Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fgeed.2025.1582097Best OA location URL: https://www.frontiersin.org/journals/genome-editing/articles/10.3389/fgeed.2025.1582097/pdfCitation Count: 8
-
OPENTitle: Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degenerationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 186End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01047-3Best OA location URL: https://www.nature.com/articles/s41531-025-01047-3.pdfCitation Count: 1
-
OPENTitle: Longitudinal brain structure changes in Parkinson’s disease: A replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 1Start Page: e0295069End Page: e0295069Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0295069Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295069&type=printableCitation Count: 9
-
OPENTitle: NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian EfficacyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 6Start Page: 1134End Page: 1142Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.30175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30175Citation Count: 14
- Enrichment analysis for spatial and single-cell metabolomics accounting for molecular ambiguity2024OPENTitle: Enrichment analysis for spatial and single-cell metabolomics accounting for molecular ambiguityJournal Name: Bioinformatics AdvancesPublisher: Oxford University Press (OUP)Vol: 5Issue #: 1Start Page: vbaf100End Page: vbaf100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bioadv/vbaf100Best OA location URL: https://academic.oup.com/bioinformaticsadvances/advance-article-pdf/doi/10.1093/bioadv/vbaf100/63264614/vbaf100.pdfCitation Count: 4
-
OPENTitle: Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson’s disease motor severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 164End Page: 164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01010-2Best OA location URL: https://www.nature.com/articles/s41531-025-01010-2.pdfCitation Count: 8
-
OPENTitle: Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page: 1582362End Page: 1582362Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1582362Best OA location URL: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1582362/pdfCitation Count: 1
-
OPENTitle: Clinical correlates of data-driven subtypes of deep gray matter atrophy and dopamine availability in early Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 165End Page: 165Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01037-5Best OA location URL: https://www.nature.com/articles/s41531-025-01037-5.pdfCitation Count: 2
-
OPENTitle: Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI studyJournal Name: Clinical and Translational SciencePublisher: WileyVol: 17Issue #: 1Start Page: e13720End Page: e13720Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.13720Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13720Citation Count: 5
-
OPENTitle: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trialsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 193End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01041-9Best OA location URL: https://www.nature.com/articles/s41531-025-01041-9.pdfCitation Count: 2